PharmAust’s (ASX:PAA) subsidiary Epichem Obtains WasteSorted e-Waste Grant

  • January 22, 2021 02:53 PM AEDT
  • Kunal Sawhney
    Kunal Sawhney
    CEO Kunal Sawhney
    2781 Posts

    Kunal Sawhney is founder & CEO at Kalkine and is a richly experienced and accomplished financial professional with a wealth of knowledge in the Australian Equities Market. Kunal obtained a Master of Business Administration degree from University of T...

PharmAust’s (ASX:PAA) subsidiary Epichem Obtains WasteSorted e-Waste Grant

Summary

  • Epichem, PharmAust’s wholly-owned subsidiary, has obtained WasteSorted e-Waste Grant worth A$200K from WA Government New Industries Fund.
  • The grant will see Epichem use Oxidative Hydrothermal Dissolution technology for converting e-waste into useful products.
  • The technology has the potential to offer substantial benefits across several industries and will support the economy by creating jobs.

ASX-listed a clinical-stage oncology player PharmAust Limited (ASX:PAA) announced that the Company’s wholly-owned subsidiary, Epichem Pty Ltd, has obtained WasteSorted e-Waste Grant from the WA government.

Post this announcement, PAA shares moved north and were trading at A$0.100, an increase of 2.040%. The market capitalisation of the Company stood at A$31.03 million.

Let us deep dive and discuss in detail-

About PharmAust Limited

A clinical-stage company, PharmAust Limited, is developing therapeutics to treat both humans and animals. The Company focuses on the marketed drug repurposing and hence reducing the risks as well as development costs.

WasteSorted e-Waste Grant of A$200K to Epichem

On 22 January 2021, PharmAust disclosed that Epichem had been awarded a A$200,000 from the Western Australian Government New Industries Fund.

These funding will see Epichem use Oxidative Hydrothermal Dissolution (OHD) technology for converting e-waste into useful end products. With this process, valuable metals and produce useful high-value chemicals can be recovered.

Source: PAA AGM Presentation (5 November 2020)

Moreover, the Company notified that the R&D program would support a new and innovative solution for processing collected e-waste. Notably, this will decrease the e-waste amount ending up in the landfill.

Epichem in a nutshell

Western Australia based Epichem offers its services and products in medicinal chemistry. The subsidiary of PharmAust offers its services to the global drug discovery and pharmaceutical companies across more than 40 nation for over 17 years.

PharmAust to support recycling and waste reduction

The grants aids WA Waste Avoidance and Resource Recovery Strategy 2030 objectives. These include:

  • To avoid waste.
  • Recover more value as well as resources from waste.
  • Avoid the impacts of waste on the environment.

Source: Megapixl

Moreover, the Company notified that the A$16.7 million New Industries Fund was established to provide business support. These funds will also increase new and emerging businesses for the diversification of Western Australia’s economy and generate new jobs.

Mr Colin La Galia CEO Epichem said:

Further, Mr Galia added that technology can provide substantial benefits across several industries, supporting the economy, and positively affecting the environment.

Adding to this, Dr Roger Aston, PharmAust’s Executive Chairman, stated:

ALSO READ: PharmAust (ASX:PAA) begins research on Monepantel COVID-19 testing

 

 


Disclaimer
The website https://kalkinemedia.com/au is a service of Kalkine Media Pty. Ltd. (Kalkine Media) A.C.N. 629 651 672. The principal purpose of the content on this website is to provide factual information only and does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) or engage in any investment activity under discussion. We are neither licensed nor qualified to provide investment advice through this platform. In providing you with the content on this website, we have not considered your objectives, financial situation or needs. You should make your own enquiries and obtain your own independent advice prior to making any financial decisions.
Some of the images that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed on this website unless stated otherwise. The images that may be used on this website are taken from various sources on the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image. The information provided on the website is in good faith, however Kalkine Media does not make any representation or warranty regarding the content, accuracy, or use of the content on the website.

 

   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK